Geneva, May 20 -- International Clinical Trials Registry received information related to the study (NCT06959004) titled 'Substance P-Induced Migraine Attacks Without Aura' on May 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Danish Headache Center

Condition: Migraine

Intervention: Drug: Substance P

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: May 12, 2025

Target Sample Size: 21

Countries of Recruitment: Denmark

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06959004

Disclaimer: Curated by HT Sy...